Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.

This Poster will be available on the Company's website on the "Publications: Posters & Presentations” page under the "Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for ...

During a Rajya Sabha session, Shri Prataprao Jadhav, the Minister of State in the Ministry of Health and Family Welfare, ...

Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program ResultsMISSISSAUGA, Ontario, April 09, 2025 (GLOBE ...

A student presents her research poster to Katia Del Rio Tsonis ... Brown’s research project concentrated on antibiotic resistance. Fernandes added this is a valuable opportunity for first-year ...

A meningitis outbreak is sweeping through Ghana’s Upper West region, exposing a struggling health care system. With ...

Under the National Antimicrobial Resistance Surveillance Network (NARS ... Awareness campaigns, including posters, videos, and radio jingles in 12 languages, have also been launched.

The poster presented at ECCMID was ... as experts raise concerns about antibiotic resistance. Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA ...